Raltitrexed plus Gemcitabine (TOMGEM) in Advanced Pancreatic Cancer

Publisher： Karger

E-ISSN： 1423-0232|67|5-6|338-343

ISSN： 0030-2414

Source： Oncology, Vol.67, Iss.5-6, 2005-02, pp. : 338-343

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Second-Line Treatment of Advanced Gastric Cancer with Oxaliplatin plus Raltitrexed

By  

Oncology Research and Treatment, Vol. 26, Iss. 3, 2003-07 ,pp. : 255-258

Karger

Access to resources Recommend Favorite

Irinotecan plus Gemcitabine and 5-Fluorouracil in Advanced Pancreatic Cancer: A Phase II Study

By  

Oncology, Vol. 72, Iss. 5-6, 2008-01 ,pp. : 279-284

Karger

Access to resources Recommend Favorite

Phase II Study of Gemcitabine plus Docetaxel in Advanced Pancreatic Cancer: A Hoosier Oncology Group Study

By  

Oncology, Vol. 65, Iss. 3, 2003-12 ,pp. : 218-223

Karger

Access to resources Recommend Favorite

Biweekly gemcitabine plus S‐1 for locally advanced and metastatic pancreatic cancer: a preliminary feasibility study

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 22, Iss. 9, 2015-09 ,pp. : 692-698

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patients with Advanced Pancreatic Cancer and Hyperbilirubinaemia: Review and German Expert Opinion on Treatment with nab-Paclitaxel plus Gemcitabine

By  

Oncology Research and Treatment, Vol. 38, Iss. 11, 2015-0 ,pp. : 596-603

Karger

Access to resources Recommend Favorite